Article Text

Download PDFPDF

167
CSF IMMUNOPHENOTYPING IN PATIENTS WITH NEUROINFLAMMATORY DISEASE
Free
  1. Mark Willis1,
  2. Kristin Ladell2,
  3. James McLaren2,
  4. Sian Llewellyn-Lacey2,
  5. Kelly Miners2,
  6. Mat Clement2,
  7. David Price2,
  8. Neil Robertson1,
  9. Linda Wooldridge3
  1. 1Institute of Psychological Medicine & Clinical Neuroscience, Cardiff University
  2. 2Institute of Infection & Immunity, Cardiff University
  3. 3Faculty of Medical and Veterinary Sciences, Bristol University

Abstract

Introduction Multiple sclerosis (MS) has a presumed autoimmune aetiology involving complex interactions between at risk genotypes and environmental factors. Immune reactivity mediated by CD4+ and CD8+ T-cells in particular is thought to drive disease pathogenesis. As part of a wider research project, we used polychromatic flow cytometry to conduct a high definition analysis of infiltrating T-cell populations in the cerebrospinal fluid (CSF) of patients with neuroinflammatory disease.

Methods Patients attending for routine diagnostic lumbar puncture as part of their neuroinflammatory disease work-up at the University Hospital of Wales were consented to participate in this study. Sample collection started in August 2013 and is currently ongoing. In each case, the entire cell population from 10 mL of CSF was stained with a purpose-built panel comprising 13 directly conjugated monoclonal antibodies. Phenotypic analysis was performed using a custom-modified FACS Aria II flow cytometer with FlowJo software.

Results Across all patients (n=16), CD4 T-cells (mean=3,548/10 mL) predominated over CD8 T-cells (mean=545/10 mL) in CSF. The majority of CD8+ T cells had an effector memory phenotype with approximately 60% exhibiting a TEMRA phenotype (CD45RA+CCR7−).

Discussion These data extend previous immunophenotypic studies and define highly characteristic subsets of memory T-cells in the CSF of patients with neuroinflammatory disease.

  • EPILEPSY

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.